Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
4
×
life sciences
national blog main
national top stories
roche
4
×
san francisco top stories
biotech
boston blog main
boston top stories
national
new york top stories
san francisco blog main
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
drug prices
drugs
gene therapy
genentech
indiana blog main
indiana top stories
investing
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acute myeloid leukemia
american society of clinical oncology
What
fda
4
×
drug
approved
cancer
medicine
new
roche
ahead
approval
asco
atrophy
bio
blueprint
branded
candidate
choices
commissioner
consumers
costly
counterweight
currently
daily
deeper
dna
drugs
elevatebio
evrysdi
fingerprint
friday
generic
genetic
going
graft
green
home
intended
lights
liquid
marketing
matter
Language
unset
Current search:
roche
×
fda
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
